UTHealth researchers identify genes in children linked to stress, bipolar disorder
HOUSTON – (May 8, 2017) – Genetic alterations that can be modulated by stress have been identified in children at high risk for bipolar disorder, according to a recently published study by researchers at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth). Results appeared in Translational Psychiatry, a Nature Publishing Group journal.
"We've known that children of patients with bipolar disorder have a higher risk of developing the illness but the biological mechanisms are largely unknown," said Gabriel R. Fries, Ph.D., first author and a post-doctoral research fellow in the Department of Psychiatry and Behavioral Sciences at McGovern Medical School at UTHealth. "By analyzing the blood of children of controls and comparing it to children of bipolar patients, we identified several genes or markers that can explain the increased risk."
Researchers analyzed peripheral blood mononuclear cells from a total of 18 children and adolescents in three matched groups: bipolar patients, unaffected offspring of bipolar parents and children of parents with no history of psychiatric disorders.
The analysis revealed that, compared to children in the control group, bipolar patients and unaffected offspring of bipolar parents had genetic alterations that can influence the response to stress.
"All combine to modulate the response to stress in these children," Fries said. "We know from clinical studies of behavior and the environment that when children are chronically exposed to stressors, they are at a higher risk of developing bipolar disorder. Bipolar parents may struggle because of their disease, leading to higher environmental stress. Their children, because of the genetic markers they have, could be more vulnerable to stress."
The genetic alterations that researchers discovered were validated in blood samples of unrelated adult bipolar patients, Fries said.
New avenues of research could include the effects of reducing environmental stress, as well as whether pharmacological agents might be able to reverse the genetic alternations in vulnerable children before the disorder develops.
Blood samples for the research came from the innovative Pediatric Bipolar Registry at the UTHealth Center of Excellence on Mood Disorders. The research was supported in part by grants from the Pat Rutherford, Jr. Endowed Chair in Psychiatry and the John S. Dunn Foundation.
Senior author is Jair C. Soares, M.D., Ph.D., professor, chairman and the Pat R. Rutherford, Jr. Endowed Chair in the Department of Psychiatry and Behavioral Sciences at McGovern Medical School.
Co-authors from McGovern Medical School are Iram Kazimi, M.D., assistant professor; Cristian P. Zeni, M.D., Ph.D., assistant professor and director of the Mood Disorders Clinic for Children and Adolescents; Giovana Zunta-Soares, M.D., assistant professor and director of the Mood Disorders Clinical Trial Program; Consuelo Walss-Bass, Ph.D., associate professor and co-director of the Translational Psychiatry Program; and Joao L. de Quevedo, M.D., Ph.D., professor, vice-chair and director of the Translational Psychiatry Program. Soares, Walss-Bass and de Quevedo are faculty members of the Neuroscience Graduate Program at The University of Texas MD Anderson Center Center UTHealth Graduate School of Biomedical Sciences.
Deborah Mann Lake